Freenome, Inc. (FRNM) stock
FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.93+0.20 (+2.00%)
Close on Nov 19, 2026Market cap $1.10BP/E –Yield –
Freenome net income
Net income is the profit left for shareholders after every expense, interest and tax.
Freenome's net income for the twelve months ending Sep 30, 2026 was $109.43M. For fiscal 2025 it was $837.47K.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $837.47K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $60.11M | – |
| Q2 FY2026 | Jun 30, 2026 | -$69.03M | – |
| Q1 FY2026 | Mar 31, 2026 | -$63.56M | – |
| Q4 FY2025 | Dec 31, 2025 | $181.91M | +18434.4% |
| Q3 FY2025 | Sep 30, 2025 | -$64.47M | -62767.3% |
| Q2 FY2025 | Jun 30, 2025 | -$58.73M | – |
| Q1 FY2025 | Mar 31, 2025 | -$57.87M | – |
| Q3 FY2024 | Sep 30, 2024 | $981.48K | – |
| Q2 FY2024 | Jun 30, 2024 | $102.88K | – |
See a number that looks wrong?